News & events

Upcoming events

See all upcoming events

Latest news

Morphotek®, Inc. Announces an Agreement With Fujirebio Diagnostics, Inc to commercialize the CA125 II Assay as a Companion Diagnostic for Farletuzumab®

Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it entered into a collaboration and license agreement with Fujirebio Diagnostics, Inc. (Fujirebio Diagnostics) to validate and commercialize the CA125 II assay for use on the Lumipulse® Instrument System as a companion diagnostic to aid in the selection of ovarian cancer patients who may best respond to Morphotek’s investigational antibody, farletuzumab.

Read more

Fujirebio Europe announces the CE-marking of the Lumipulse® G Total Tau assay and extends its offer of fully automated assays aiding in the early diagnosis of Alzheimer’s disease

Fujirebio Europe today announced the CE-marking of the Lumipulse G Total Tau assay for its fully automated LUMIPULSE immunoassay systems. This CLEIA (chemiluminescent enzyme immunoassay) kit allows for the quantitative determination of total Tau in human cerebrospinal fluid within just 35 minutes.

Read more

Fujirebio Europe launches Lumipulse® G β-Amyloid 1-42, a fully automated assay aiding in the early diagnosis of neurodegeneration

Fujirebio Europe today announced the release of the Lumipulse G β-Amyloid 1-42 assay for its fully automated LUMIPULSE immunoassay systems. This CE-marked CLEIA (chemiluminescent enzyme immunoassay) kit allows the quantitative measurement of β-amyloid1-42 in human cerebrospinal fluid within just 30 minutes. The Lumipulse G β-Amyloid 1-42 assay is based upon Fujirebio’s well established, pioneering ELISA-based INNOTEST® assay (the first neurodegeneration testing kit launched in 1995) and the know-how of Fujirebio in robust and automated CLEIA testing since the first LUMIPULSE instrument was released in 1992.

Read more

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.